Dominique Johnson joined the McPeak-Sirois Group in March 2016 as General Manager; she brought her vast knowledge and experience in clinical research to rapidly develop and operationalize the Group’s activities. A graduate of the University of Montreal with a Ph.D. in Biomedical Sciences and a specialty in cardiovascular clinical research, Dominique has been involved in clinical research for almost 20 years both in private and public health organizations. She began her career in the pharmaceutical industry where she has significantly contributed to their cardiovascular clinical research program.
In 2000, Dominique co-founded the Montreal Health Innovations Coordinating Center (MHICC), a division of the Montreal Heart Institute, an academic research organization, and acted as its executive director for 16 years. She was responsible for its establishment, development and growth and under her leadership, the MHICC gained an international reputation. She established a successful business model that supports both academic clinical research and contract research with the biopharmaceutical industry, as demonstrated by the presentation of the 2012 Innovation Award to MHICC by the Armand-Frappier Foundation.
Dominique has sat on Steering and Operations Committees of several large international phase III multi-center cardiovascular clinical trials. She developed many partnerships within the clinical research community, including the biopharmaceutical industry, clinical research organizations, investigators and healthcare institutions. Dominique has authored more than 40 publications in journals including the Journal of the American College of Cardiology, the American Heart Journal and Atherosclerosis.
In January 2018, Nathalie Laplante was proud to join the McPeak-Sirois Group as coordinator of the Programme Accès-recherche whose mission is to extend the consortium’s action to hospitals in regions all over Quebec.
Nathalie obtained her Ph.D. in clinical psychology and psychopathology from Université Paris-8 (France) in 1996. She has over 20 years of experience in clinical trial management both in public health organizations and the biopharma industry.
Nathalie co-founded Galileo Genomics (later Genizon Biosciences) in 1999, a population genomics company based in Montreal. She held the position of Senior Director of the Clinical Research and Ethics department. Among other accomplishments, she developed an important network of clinical collaborators throughout Quebec with which studies involving over 20 diseases and conditions could be conducted.
She later joined the Montreal Heart Institute (MHI) (2005) were she was entrusted with key mandates, such as establishing and managing the MHI Biobank, a 30,000-patient hospital cohort. As Global Project Manager, she later proceeded to manage phase III industry sponsored international studies at the Montreal Health Innovations Coordinating Center (MHICC), a worldwide renowned academic research organization part of MHI.
Marine Baillie joined the McPeak-Sirois Group when it was launched in October 2015, initially as Development Advisor. Marine graduated from the University of Toulouse 1 in France with a master’s degree in communication and has nearly 15 years of experience in managing communication mandates for global companies.
Marine has recently lent her expertise as Director of Communications, to several non-profit organizations, including the QG100 Network and Enablis Entrepreneurial Network.
Marine is working to highlight the achievements and progress of the McPeak-Sirois Group, as well as develop optimal communication with its member hospitals.